Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene Expression
Johnson & Johnson (United States) · Duke Medical Center
Abstract
PURPOSE: Breast cancer arising in young women is correlated with inferior survival and higher incidence of negative clinicopathologic features. The biology driving this aggressive disease has yet to be defined. PATIENTS AND METHODS: Clinically annotated, microarray data from 784 early-stage breast cancers were identified, and prospectively defined, age-specific cohorts (young: /= 65 years, n = 211) were compared by prognosis, clinicopathologic variables, mRNA expression values, single-gene analysis, and gene set enrichment analysis (GSEA). Univariate and multivariate analyses were performed. RESULTS: Using clinicopathologic variables, young women illustrated lower estrogen receptor (ER) positivity…
Citation impact
- FWCI
- 12.98
- Percentile
- 100%
- References
- 43
Authors
13- CKCarey K. AndersCorresponding
Johnson & Johnson (United States), Duke Medical Center
- DSDavid S. Hsu
Johnson & Johnson (United States), Duke Medical Center
- GBGloria Broadwater
Johnson & Johnson (United States), Duke Medical Center
- CRChaitanya R. Acharya
Johnson & Johnson (United States), Duke Medical Center
- JAJohn A. Foekens
Johnson & Johnson (United States), Duke Medical Center
Topics & keywords
- Breast cancer
- Medicine
- Estrogen receptor
- Immunohistochemistry
- Oncology
- Univariate analysis
- Internal medicine
- Hazard ratio
- Good health and well-being